文献速递主动脉外科冠心病外科瓣膜外科

预防性主动脉替换联合心脏手术的风险评估

Risk of adding prophylactic aorta replacement to a cardiac operation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-05-18

该研究通过倾向性匹配分析发现,当主动脉病变较轻且非主要手术指征时,在心脏手术中加做预防性主动脉替换不增加院内卒中或死亡风险;但若主动脉病变严重且为主要指征,则风险显著升高。

要点

  • 主动脉扩张<5.5 cm且非主要指征时,联合预防性主动脉替换不增加卒中或死亡风险。
  • 主动脉病变严重且为主要指征时,联合手术的院内卒中与死亡发生率显著增高。
  • 手术决策时应区分主动脉病变的严重程度及是否为手术主要指征。

核心结论

  • 当主动脉病变较轻且非主要手术指征时,预防性主动脉替换可安全联合心脏手术,不增加额外风险。
  • 当晚期主动脉病变为主要手术指征时,联合主动脉替换的风险可能相当大。

研究设计与样本

  • 倾向性匹配研究,将心脏联合主动脉替换患者匹配为联合手术非主要因主动脉疾病指征者(n=684)。
  • 进一步在不考虑胸主动脉测量的情况下与仅心脏手术患者进行倾向性匹配,得到647对比较结局。

主要发现

  • 匹配患者中多数(431/503[86%])升主动脉扩张且最大主动脉直径小于5.5 cm。

临床怎么用

  • 对于主动脉扩张较轻且非主要手术指征的心脏手术患者,可考虑同期行预防性主动脉替换而不必担心额外风险。
  • 当主动脉病变严重且为主要手术指征时,应充分评估联合手术的卒中与死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to determine whether adding prophylactic aorta replacement increases the risk of a cardiac operation when cardiac rather than aortic disease is the primary indication for operation. METHODS: Patients undergoing cardiac operations with aorta replacement (cardioaortic group), with or without circulatory arrest, were propensity matched to identify patients whose combined operation was not primarily indicated by aortic disease (n = 684). These patients were further propensity matched without accounting for thoracic-aortic measurements to patients undergoing cardiac operations without aorta replacement (cardiac-surgery only group), 647 pairs, for comparing outcomes. RESULTS: Most (n = 431/503 [86%]) propensity-matched patients undergoing cardioaortic operations had ascending aorta dilatation with a maximum aortic diameter of less than 5.5 cm. There was no evidence of an incremental increase in risk of in-hospital stroke (cardioaortic, n = 9/1.4% vs cardiac only, n = 7/1.1%; P = .6) or mortality (cardioaortic, n = 6/0.93% vs cardiac only, n = 3/0.46%; P = .5). Unmatched patients undergoing concomitant aortic surgery had advanced aortic disease distal to the ascending aorta (arch, 3.8 ± 0.98 cm vs 3.2 ± 0.51 cm; descending, 4.4 ± 1.7 cm vs 3.2 ± 0.99 cm) as the primary indication for their operation and had a high occurrence of in-hospital stroke (6.5% vs 1.5%, P = .0007) and death (7% vs 1.2%, P = .0001). CONCLUSIONS: Prophylactic aorta replacement can be safely performed during a cardioaortic operation, without added penalty, when aortic disease is less severe and not the primary indication for surgery. Risks after an aorta replacement combined with cardiac surgery can be substantial, however, when advanced aortic disease is the primary indication for operation. These distinctive risks should be taken into consideration at the time of surgical decision-making.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Idrees JJ, Roselli EE, Blackstone EH, et al. Risk of adding prophylactic aorta replacement to a cardiac operation. J Thorac Cardiovasc Surg. 2019. PMID: 31256966. doi:10.1016/j.jtcvs.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。